Skip to main content
OpenTrials

Clinical trial condition

Nasopharyngeal Diseases

Explore clinical trials studying Nasopharyngeal Diseases. Study availability and eligibility vary by location and protocol.

494 public trials 162 recruiting studies
Refine in advanced search Browse all conditions

Nasopharyngeal Diseases trial results

Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

NCT06064097

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 86 locations
View Trial Details
Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

NCT06980038

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +41 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Ochsner Medical Center Jefferson New Orleans, Louisiana, United States
View Trial Details
Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NCT06532279

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +62 more
Locations
  • Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
  • Arizona Center for Cancer Care - Phoenix Phoenix, Arizona, United States
  • Arizona Center for Cancer Care - Scottsdale Scottsdale, Arizona, United States
View all 153 locations
View Trial Details
Recruiting

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

NCT05592626

Conditions
Abdominal Neoplasm, Abdominal Neoplasms, Adenocarcinoma, +91 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • The University of Kansas Cancer Center Kansas City, Kansas, United States
View all 19 locations
View Trial Details
Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

NCT06029270

Conditions
Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +14 more
Locations
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
  • Kaiser Permanente Fresno Orchard Plaza Fresno, California, United States
  • Kaiser Permanente-Fresno Fresno, California, United States
View all 88 locations
View Trial Details
Recruiting

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

NCT06457503

Conditions
Head and Neck Neoplasms, Nasopharyngeal Cancer Recurrent, Nasopharyngeal Diseases, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Irvine Irvine, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
View all 13 locations
View Trial Details

Related conditions